223 related articles for article (PubMed ID: 34433514)
1. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
[TBL] [Abstract][Full Text] [Related]
2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
3. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
4. Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
Zheng H; Yin X; Pan T; Tao X; Xu X; Li Z
BMC Cancer; 2023 Nov; 23(1):1130. PubMed ID: 37990193
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
6. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
9. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
10. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis.
Wu H; Shang L; Du F; Fu M; Liu J; Fang Z; Li L
Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1107-1117. PubMed ID: 32757864
[TBL] [Abstract][Full Text] [Related]
11. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
[TBL] [Abstract][Full Text] [Related]
12. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
[No Abstract] [Full Text] [Related]
13. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
14. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
15. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
16. [Short-term outcomes and long-term quality of life after undergoing radical proximal gastrectomy with esophageal gastric tube anastomosis and total gastrectomy with Roux-en-Y anastomosis for Siewert type II and III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis].
Xu ZW; Zhao K; Hong QQ; Chen YF; Wang HB; Lin HX; Wang TH; Xiao LB; Zhu JT; Yan S; You J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Feb; 26(2):181-190. PubMed ID: 36797565
[No Abstract] [Full Text] [Related]
17. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
18. Comparative study of laparoscopic-assisted and open total gastrectomy for Siewert Types II and III adenocarcinoma of the esophagogastric junction.
Wang J; Wang JC; Song B; Dai XD; Zhang XY
J Cell Physiol; 2019 Jul; 234(7):11235-11239. PubMed ID: 30478913
[TBL] [Abstract][Full Text] [Related]
19. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
[TBL] [Abstract][Full Text] [Related]
20. Surgical and survival outcomes after laparoscopic and open gastrectomy for serosa-invasive Siewert type II/III esophagogastric junction carcinoma: a propensity score matching analysis.
Lin X; Wan J; Li Z; Yan M; Liu J; Shi Y; Qian F; Zhao Y
Surg Endosc; 2022 Jul; 36(7):5055-5066. PubMed ID: 34761283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
